Diabetes cell therapies take evasive action
Elie Dolgin • February 25, 2022
Protective encapsulating devices and gene-editing technologies could obviate the need for antirejection drugs in stem-cell-derived therapies for diabetes.
Continue reading at Nature Biotechnology.
Animals that researchers call “supersucklers” come back for their mother’s milk even after they can hunt, mate and fend for themselves.
Destroying dysfunctional tissue could reset metabolism.